BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 24102808)

  • 1. Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation.
    Putnam AL; Safinia N; Medvec A; Laszkowska M; Wray M; Mintz MA; Trotta E; Szot GL; Liu W; Lares A; Lee K; Laing A; Lechler RI; Riley JL; Bluestone JA; Lombardi G; Tang Q
    Am J Transplant; 2013 Nov; 13(11):3010-20. PubMed ID: 24102808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of Human Alloantigen-Specific Regulatory T Cells Under Good Manufacturing Practice-Compliant Conditions for Cell Therapy.
    Cheraï M; Hamel Y; Baillou C; Touil S; Guillot-Delost M; Charlotte F; Kossir L; Simonin G; Maury S; Cohen JL; Lemoine FM
    Cell Transplant; 2015; 24(12):2527-40. PubMed ID: 25198125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification, selection, and expansion of non-gene modified alloantigen-reactive Tregs for clinical therapeutic use.
    Alzhrani A; Bottomley M; Wood K; Hester J; Issa F
    Cell Immunol; 2020 Nov; 357():104214. PubMed ID: 32977154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alloantigen-specific CD4(+) regulatory T cells induced in vivo by ultraviolet irradiation after alloantigen immunization require interleukin-10 for their induction and activation, and flexibly mediate bystander immunosuppression of allograft rejection.
    Hori T; Kuribayashi K; Saito K; Wang L; Torii M; Uemoto S; Kato T
    Transpl Immunol; 2015 Jun; 32(3):156-63. PubMed ID: 25861842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of immunosuppressants on the therapeutic efficacy of in vitro-expanded CD4+CD25+Foxp3+ regulatory T cells in allotransplantation.
    Lim DG; Koo SK; Park YH; Kim Y; Kim HM; Park CS; Kim SC; Han DJ
    Transplantation; 2010 Apr; 89(8):928-36. PubMed ID: 20305583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel GMP-compatible protocol employing an allogeneic B cell bank for clonal expansion of allospecific natural regulatory T cells.
    Landwehr-Kenzel S; Issa F; Luu SH; Schmück M; Lei H; Zobel A; Thiel A; Babel N; Wood K; Volk HD; Reinke P
    Am J Transplant; 2014 Mar; 14(3):594-606. PubMed ID: 24467477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts.
    Giorgini A; Noble A
    J Leukoc Biol; 2007 Nov; 82(5):1053-61. PubMed ID: 17684039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory T-cell therapy for transplantation: how many cells do we need?
    Tang Q; Lee K
    Curr Opin Organ Transplant; 2012 Aug; 17(4):349-54. PubMed ID: 22790069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor reactive regulatory T cells.
    Feng G; Chan T; Wood KJ; Bushell A
    Curr Opin Organ Transplant; 2009 Aug; 14(4):432-8. PubMed ID: 19448539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokines affecting CD4(+) T regulatory cells in transplant tolerance. Interleukin-4 does not maintain alloantigen specific CD4(+)CD25(+) Treg.
    Plain KM; Verma ND; Tran GT; Nomura M; Boyd R; Robinson CM; Hodgkinson SJ; Hall BM
    Transpl Immunol; 2013 Dec; 29(1-4):51-9. PubMed ID: 24139939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection.
    Boardman DA; Philippeos C; Fruhwirth GO; Ibrahim MA; Hannen RF; Cooper D; Marelli-Berg FM; Watt FM; Lechler RI; Maher J; Smyth LA; Lombardi G
    Am J Transplant; 2017 Apr; 17(4):931-943. PubMed ID: 28027623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vivo Development of Transplant Arteriosclerosis in Humanized Mice Reflects Alloantigen Recognition and Peripheral Treg Phenotype of Lung Transplant Recipients.
    Siemeni T; Knöfel AK; Madrahimov N; Sommer W; Avsar M; Salman J; Ius F; Frank N; Büchler G; Jonigk D; Jansson K; Maus U; Tudorache I; Falk CS; Haverich A; Warnecke G
    Am J Transplant; 2016 Nov; 16(11):3150-3162. PubMed ID: 27273729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infiltrating Foxp3(+) regulatory T cells from spontaneously tolerant kidney allografts demonstrate donor-specific tolerance.
    Hu M; Wang C; Zhang GY; Saito M; Wang YM; Fernandez MA; Wang Y; Wu H; Hawthorne WJ; Jones C; O'Connell PJ; Sparwasser T; Bishop GA; Sharland AF; Alexander SI
    Am J Transplant; 2013 Nov; 13(11):2819-30. PubMed ID: 24102948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-gamma triggered STAT1-PKB/AKT signalling pathway influences the function of alloantigen reactive regulatory T cells.
    Wei B; Baker S; Wieckiewicz J; Wood KJ
    Am J Transplant; 2010 Jan; 10(1):69-80. PubMed ID: 19889125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A converse 4-1BB and CD40 ligand expression pattern delineates activated regulatory T cells (Treg) and conventional T cells enabling direct isolation of alloantigen-reactive natural Foxp3+ Treg.
    Schoenbrunn A; Frentsch M; Kohler S; Keye J; Dooms H; Moewes B; Dong J; Loddenkemper C; Sieper J; Wu P; Romagnani C; Matzmohr N; Thiel A
    J Immunol; 2012 Dec; 189(12):5985-94. PubMed ID: 23162126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of allogeneic cardiac graft rejection by transfer of ex vivo expanded antigen-specific regulatory T-cells.
    Takasato F; Morita R; Schichita T; Sekiya T; Morikawa Y; Kuroda T; Niimi M; Yoshimura A
    PLoS One; 2014; 9(2):e87722. PubMed ID: 24498362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro expanded alloantigen-specific CD4+CD25+ regulatory T cell treatment for the induction of donor-specific transplantation tolerance.
    Jiang S; Golshayan D; Tsang J; Lombardi G; Lechler RI
    Int Immunopharmacol; 2006 Dec; 6(13-14):1879-82. PubMed ID: 17161340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adoptive transfer of CD4+CD25+ regulatory cells combined with low-dose sirolimus and anti-thymocyte globulin delays acute rejection of renal allografts in Cynomolgus monkeys.
    Ma A; Qi S; Song L; Hu Y; Dun H; Massicotte E; Dupuis M; Daloze P; Chen H
    Int Immunopharmacol; 2011 May; 11(5):618-29. PubMed ID: 21094689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treg therapy in transplantation: a general overview.
    Romano M; Tung SL; Smyth LA; Lombardi G
    Transpl Int; 2017 Aug; 30(8):745-753. PubMed ID: 28012226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comparison of
    Lee LM; Zhang H; Lee K; Liang H; Merleev A; Vincenti F; Maverakis E; Thomson AW; Tang Q
    Front Immunol; 2021; 12():679675. PubMed ID: 34220826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.